10-Q · May 8, 2026
Axcelis Technologies reported Q1 2026 results with revenue of $198.96 million, slightly exceeding estimates, and a diluted EPS of $0.72, beating expectations of $0.68. While revenue increased 3.3% year-over-year, gross…
Earnings analysis · 10-Q
ACLS earnings analysis
Filed November 5, 2026 · Our reading of the company's report
The latest report
Axcelis reported Q3 2026 revenue of $237.781 million and diluted EPS of $1.26, beating consensus estimates of $230.075 million and $1.06. The filing excerpt does not include the current quarter’s gross margin, operating…
Read full summary
Axcelis reported Q3 2026 revenue of $237.781 million and diluted EPS of $1.26, beating consensus estimates of $230.075 million and $1.06. The filing excerpt does not include the current quarter’s gross margin, operating margin, cash flow, balance-sheet, or segment data, limiting assessment of profitability and cash-generation trends. Controls were effective, no material risk-factor changes were reported as of September 30, 2026, and approximately $110 million remained available for repurchases, but no buybacks occurred during the quarter.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $1.26
What stood out
-
Revenue and EPS beat estimates
Q3 2026 revenue was $237.781 million and diluted EPS was $1.26, exceeding consensus estimates of $230.075 million and $1.06, respectively.
-
Controls remained effective
Management reported that disclosure controls and procedures were effective as of September 30, 2026, and that there were no material changes to internal control over financial reporting during the three months ended September 30, 2026.
-
$110 million remains for buybacks
The company had no share repurchase activity during the three months ended September 30, 2026, while approximately $110 million remained available under the repurchase program as of September 30, 2026.
-
No material litigation identified
The company reported no litigation presently expected to have a material adverse effect on operations as of September 30, 2026.
What to watch
-
Existing risk profile remains unchanged
As of September 30, 2026, the company stated that there had been no material changes to the risk factors disclosed in its 2025 Form 10-K; therefore, existing risks remain applicable without additional quarterly detail.
-
Buyback activity remained absent
No repurchases occurred during the three months ended September 30, 2026, despite approximately $110 million remaining available under the program as of September 30, 2026; this may indicate that capital deployment remains discretionary or subject to changing priorities.
-
Market-risk disclosures unchanged
The filing states that no material changes occurred in quantitative or qualitative market-risk disclosures as of September 30, 2026, so the filing does not reduce exposure to previously disclosed market risks.
Management's outlook
The 10-Q excerpt does not provide numeric guidance. The accompanying November 5, 2026 earnings disclosure provided Q4 outlook of approximately $275 million revenue, $1.15 GAAP diluted EPS and $1.50 non-GAAP diluted EPS; no prior comparable outlook was disclosed.
Earlier filings 4
10-K · February 26, 2026
Axcelis reported FY2025 revenue of $839.0M and diluted EPS of $3.80, with gross margin essentially stable at 44.9% while operating profit declined to $119.3M from $210.8M in 2024. The company generated $118.3M of cash…
10-Q · November 6, 2025
Axcelis Technologies' Q3 2025 results show a slight revenue decline but exceeded analyst expectations, reporting revenues of $213.6 million and EPS of $1.21 against estimates of $200.2 million and $0.95 respectively.…
10-Q · May 6, 2025
Axcelis reported Q1 revenue of $192,563,000 and diluted EPS of $0.88 for the three months ended March 31, 2025. Revenue and earnings declined materially year-over-year, but gross margin held at 46.1% and operating cash…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.